Re-branding by parallel importer infringed pharmaceutical trade mark

In a case involving parallel imports of a drug into the UK from other European countries, the High Court held that the importer infringed the claimant’s trade marks by re-branding the European product with the brand name of the UK product.

Even though the re-branding was necessary in order for the defendants to compete on the UK market, this did not provide a defence to infringement.

Leave a comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s